Report Categories
View AllRecent Articles
View All
New York Fed Study Reveals Surging Gas Prices Hit LowerIncome Households Hardest
Sun Communities SUI Q1 2026 Earnings Miss EPS 007 vs 027 Expected
NVE Corporation NVEC Earnings Outlook Key Metrics for Q1 2026
NFL Seeks to Ban Certain Prediction Market Contracts on First Play of Game and Injuries Letter Shows
Trumps Iran Remarks Stoke Oil Market Volatility Traders Assess Supply Risks
Thai Conglomerate CP Faces Internal Dispute Over Finance Business
Cerus Corporation CERS Upgraded to Buy by BTIG Following Q1 Results
Surging Gas Prices Disproportionately Impact LowerIncome Households New York Fed Study Finds
XPeng Faces Headwinds as Major Hedge Fund Exits Entire Stake
Amazon Taps Amwell CoFounder as New Health Chief Amid Executive Departure
FGI Industries Ltd FGI Q1 2026 Earnings Strong EPS Beat Amid Challenging Environment
KFS Q1 2026 Earnings Loss Per Share of 010 Reported Stock Down Slightly
SDRL Q1 2026 Earnings NarrowerthanExpected Loss Boosts Surprise but Shares Slip
BWA Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Focus
ISBA Q1 2026 Earnings Massive EPS Miss Drives Stock Decline
INCY Q1 2026 Earnings EPS Blows Past Estimates Stock Slightly Lower
Lionheart Holdings CUB Consolidates at 1080 Key Levels Define the Next Move
Kartoon Studios TOON Slides 286 as Stock Tests Key Support Near 065
Sweetgreen Inc SG Surges 767 as Stock Approaches Key Resistance at 1047
BranchOut Food Inc BOF Slides 217 Support Test Looms
Phunware Inc PHUN Holds Steady at 202 as Key Support and Resistance Levels Converge
External Links
VolitionRx Limited VNRX Gains Attention as TopRated Penny Stock Amid Wall Street Analyst Optimism
MNST Q1 2026 Earnings EPS Beats Estimates by 83 Stock Edges Higher
BitMine Immersion Technologies BMNR Under Pressure as Shares Slide 372
ALNT Q1 2026 Earnings EPS Misses Estimates Stock Rallies 1255
AB Q1 2026 Earnings EPS Misses Estimates Amid Cautious Market Environment
NMFC Q1 2026 Earnings EPS Misses Estimates Slightly Stock Dips on Narrow Surprise
DRMA Q1 2026 Earnings NarrowerthanExpected Loss Marks Progress for ClinicalStage Biotech
Kalaris Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Biotech
RYAM Q1 2026 Earnings Significant EPS Miss Overshadowed by Modest Stock Gain
GRRR Q4 2025 Earnings Significant EPS Miss Despite Positive Stock Reaction